In 2015 was created GP Healthcare Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Shanghai. The venture was found in Asia in China.
The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this GP Healthcare Capital performs on 9 percentage points less the average number of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Therapeutics, Medical Device. Among the various public portfolio startups of the fund, we may underline Adagene, MicuRx Pharmaceuticals, Beijing Allcure Medical Technology Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the GP Healthcare Capital, startups are often financed by Morningside Group, WuXi Healthcare Ventures, MAGS Capital. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Trustbridge Partners, TitanMed Capital. In the next rounds fund is usually obtained by Sequoia Capital China, New World TMT Ltd, King Star Capital.
Related Funds
| Fund Name | Location |
| Aota Touzi | China, Guangdong, Shenzhen |
| Beyond Black | Berlin, Berlin, Germany |
| Blue Horizon Corporation | Switzerland, Zürich, Zurich |
| CampVentures | California, Los Altos, United States |
| Chuangjin Ziben | Beijing, Beijing, China |
| Early Capital | - |
| Gordon Food Service | Grand Rapids, Michigan, United States |
| Greenland Hong Kong Holdings Limited | China, Shanghai |
| Macro | California, Los Angeles, United States |
| OCA Ventures | Chicago, Illinois, United States |
| Oklahoma Life Science Fund | Oklahoma, Tulsa, United States |
| Optimist Capital | - |
| Oracle | California, Redwood Shores, United States |
| Purify | - |
| SDIC Venture Capital | China, Hebei, Xicheng |
| Seed Fond Aachen | Aachen, Germany, Nordrhein-Westfalen |
| VCF III | - |
| VivaKi | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Stand Group | 27 Jul 2023 | Qingdao Shi, Shandong, China | |||
Kingwills New Materials | $15M | 18 May 2023 | Shanghai, Shanghai, China | ||
Lingyu Technology | 28 Nov 2022 | Jiangxi, Guangdong, China | |||
Yuntian Semiconductor | 06 Dec 2021 | Xiamen, China | |||
Laekna Therapeutics | $27M | 02 Apr 2019 | Shanghai, China | ||
GenomiCare Biotechnology | $30M | 18 Dec 2018 | China, Shanghai | ||
Beijing Allcure Medical Technology | $108M | 24 Jul 2018 | China, Beijing | ||
BCC | $30M | 15 Jun 2017 | Beijing, Beijing, China | ||
MicuRx Pharmaceuticals | $55M | 26 Sep 2016 | Hayward, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Stand Group | 27 Jul 2023 | Qingdao Shi, Shandong, China | |||
Kingwills New Materials | $15M | 18 May 2023 | Shanghai, Shanghai, China | ||
Lingyu Technology | 28 Nov 2022 | Jiangxi, Guangdong, China | |||
Yuntian Semiconductor | 06 Dec 2021 | Xiamen, China | |||
Laekna Therapeutics | $27M | 02 Apr 2019 | Shanghai, China | ||
GenomiCare Biotechnology | $30M | 18 Dec 2018 | China, Shanghai | ||
Beijing Allcure Medical Technology | $108M | 24 Jul 2018 | China, Beijing | ||
BCC | $30M | 15 Jun 2017 | Beijing, Beijing, China | ||
MicuRx Pharmaceuticals | $55M | 26 Sep 2016 | Hayward, California, United States |
